Ailawadi, S., Murphy, J. E., Storandt, M. H., Rao, R., Mahipal, A. (2026). Comparative outcomes of first-line atezolizumab plus bevacizumab (A+B) and durvalumab plus tremelimumab (D+T) in hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4163